TP53BP2 and leukemia: Although the sample size tested for protein expression was not large enough to draw statistical conclusions, this proof of principle experiment is consistent with a role for the lack of ASPP2 damage-induction[23] playing a role in resistance to chemotherapy in human leukemia.